KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Change in Acquisitions & Divestments (2020 - 2026)

CRISPR Therapeutics AG (CRSP) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with -$710.6 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 290.5% to -$710.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $702000.0 through Dec 2025, down 99.94% year-over-year, with the annual reading at $702000.0 for FY2025, 99.94% down from the prior year.
  • Change in Acquisitions & Divestments hit -$710.6 million in Q4 2025 for CRISPR Therapeutics AG, down from $214.9 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $419.7 million in Q3 2022 to a low of -$710.6 million in Q4 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $220.6 million across 5 years, with a median of $242.5 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 194.21% in 2022 and later plummeted 290.5% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $123.0 million in 2021, then skyrocketed by 164.25% to $325.1 million in 2022, then decreased by 11.57% to $287.4 million in 2023, then rose by 29.77% to $373.0 million in 2024, then tumbled by 290.5% to -$710.6 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for CRSP at -$710.6 million in Q4 2025, $214.9 million in Q3 2025, and $310.2 million in Q2 2025.